Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026)
Axogen (AXGN) posted Net Income towards Common Stockholders of -$1.4 million for Q2 2026, up 50.29% on a QoQ basis from -$2.8 million in Q1 2026, and down 1613.75% year-over-year from $90569.8 in Q2 2025.
Analysis
Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Axogen has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$1.4 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 1613.75% year-over-year to -$1.4 million in Q2 2026; TTM through Jun 2026 was -$14.8 million, a 190.57% decrease from a year earlier, with the FY2025 full-year figure at -$14.4 million, down 38.94% from the prior year.
- Net Income towards Common Stockholders was -$1.4 million for Q2 2026 at Axogen, up from -$2.8 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $541000.0 in Q4 2024, with the low at -$11.7 million in Q1 2022.
- Average Net Income towards Common Stockholders over 5 years is -$4.5 million, with a median of -$4.6 million recorded in 2023.
- The largest YoY upside for Net Income towards Common Stockholders was 124.78% in 2025 against a maximum downside of 2158.78% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$5.2 million in 2022, then increased by 9.09% to -$4.7 million in 2023, then surged by 111.51% to $541000.0 in 2024, then sank by 2158.78% to -$11.1 million in 2025, then soared by 87.69% to -$1.4 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$1.4 million (Q2 2026), -$2.8 million (Q1 2026), and -$11.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Axogen | 2.51 Bn | 2.40 Bn | 50.67 Mn | -1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.37 Mn |
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -11.14 Mn |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Mar 31, 2025 | -3.64 Mn |
| Dec 31, 2024 | 541,000.00 |
| Sep 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -6.59 Mn |
| Dec 31, 2023 | -4.70 Mn |
| Sep 30, 2023 | -4.49 Mn |
| Jun 30, 2023 | -6.82 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -5.17 Mn |
| Sep 30, 2022 | -4.73 Mn |
| Jun 30, 2022 | -8.14 Mn |
| Mar 31, 2022 | -11.72 Mn |
| Dec 31, 2021 | -5.27 Mn |
| Sep 30, 2021 | -7.09 Mn |